No description
-
2013 (v1)PublicationUploaded on: April 14, 2023
-
2010 (v1)Publication
No description
Uploaded on: April 14, 2023 -
2010 (v1)Publication
No description
Uploaded on: March 27, 2023 -
2017 (v1)Publication
Objective: To retrospectively analyze the effect of plasma exchange (PLEX; yes = PLEX+, no = PLEX–) and steroids administration timing (prophylactically [proST] or therapeutically [therST]) on the longitudinal clinical course of patients with natalizumab-related progressive multifocal leukoencephalopathy (PML) and full-blown immune...
Uploaded on: March 27, 2023 -
2019 (v1)Publication
Objective early diagnosis of natalizumab-related progressive multifocal leucoencephalopathy (NTZ-pML) in multiple sclerosis has been deemed a major priority by the regulatory agencies but has yet to become a reality. The current paper aims to: (1) investigate whether patients with NTZ-pML pass through a prolonged presymptomatic phase with MRI...
Uploaded on: April 14, 2023 -
2018 (v1)Publication
In this retrospective, multicenter, real-world study we collected clinical and magnetic resonance imaging (MRI) data of all patients (n = 40) with relapsing-remitting multiple sclerosis (RRMS) treated with alemtuzumab according to a "free-of-charge" protocol available before the drug marketing approval in Italy. Almost all (39/40) started...
Uploaded on: April 14, 2023 -
2010 (v1)Publication
No description
Uploaded on: April 14, 2023